These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9430481)

  • 1. False-positive somatostatin receptor scintigraphy due to an accessory spleen.
    Lebtahi R; Cadiot G; Marmuse JP; Vissuzaine C; Petegnief Y; Courillon-Mallet A; Cattan D; Mignon M; Le Guludec D
    J Nucl Med; 1997 Dec; 38(12):1979-81. PubMed ID: 9430481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is a false-positive somatostatin receptor scintigraphy?
    Reubi JC
    J Nucl Med; 1998 Dec; 39(12):2193-4. PubMed ID: 9867170
    [No Abstract]   [Full Text] [Related]  

  • 3. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.
    Gibril F; Reynolds JC; Chen CC; Yu F; Goebel SU; Serrano J; Doppman JL; Jensen RT
    J Nucl Med; 1999 Apr; 40(4):539-53. PubMed ID: 10210211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison.
    de Kerviler E; Cadiot G; Lebtahi R; Faraggi M; Le Guludec D; Mignon M
    Eur J Nucl Med; 1994 Nov; 21(11):1191-7. PubMed ID: 7859770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making the best of imperfect tumor-localizing radiopharmaceuticals.
    Shapiro B; Gross MD
    J Nucl Med; 1999 Apr; 40(4):554-5. PubMed ID: 10210212
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.
    Gibril F; Reynolds JC; Doppman JL; Chen CC; Venzon DJ; Termanini B; Weber HC; Stewart CA; Jensen RT
    Ann Intern Med; 1996 Jul; 125(1):26-34. PubMed ID: 8644985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma].
    Hoefer M; Schmidt S; Welter J; Kirsch CM; Ukena D; Sybrecht GW
    Pneumologie; 1998 Feb; 52(2):106-12. PubMed ID: 9557059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
    Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
    J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of false-positive findings of somatostatin receptor scintigraphy in diagnosis of neuroendocrine tumors of the gastroenteropancreatic system].
    Faiss S; Scherübl H; Bäder M; Fett U; Koppenhagen K; Wiedenmann B; Riecken EO
    Z Gastroenterol; 1994 May; 32(5):243-6. PubMed ID: 7915450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Imaging of metastases from thyroid carcinomas using 111In-pentetreotide scintigraphy].
    Görges R; Eissner D; Kahaly G; Voges E; Kersjes W; Bockisch A
    Nuklearmedizin; 1995 Aug; 34(4):165-9. PubMed ID: 7675648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tc-99m red blood cell uptake in positive somatostatin receptor scintigraphy by two accessory spleens.
    Martínez-Rodríguez I; Allende RH; Banzo I; Quirce R; Jiménez-Bonilla J; Sainz-Esteban A; Carril JM
    Clin Nucl Med; 2006 Jun; 31(6):340-1. PubMed ID: 16714895
    [No Abstract]   [Full Text] [Related]  

  • 12. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.
    Jamar F; Fiasse R; Leners N; Pauwels S
    J Nucl Med; 1995 Apr; 36(4):542-9. PubMed ID: 7699439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintigraphy.
    Weinel RJ; Neuhaus C; Stapp J; Klotter HJ; Trautmann ME; Joseph K; Arnold R; Rothmund M
    Ann Surg; 1993 Nov; 218(5):640-5. PubMed ID: 7902072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors.
    Schillaci O; Scopinaro F; Angeletti S; Tavolaro R; Danieli R; Annibale B; Gualdi G; Delle Fave G
    J Nucl Med; 1996 Sep; 37(9):1452-6. PubMed ID: 8790191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma.
    Tenenbaum F; Lumbroso J; Schlumberger M; Caillou B; Fragu P; Parmentier C
    J Nucl Med; 1995 May; 36(5):807-10. PubMed ID: 7738653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor analysis of dynamic series (FADS) in somatostatin receptor imaging.
    Kolesnikov-Gauthier H; Huglo D; Nocaudie M; Marchandise X
    J Nucl Med; 1999 Jan; 40(1):33-9. PubMed ID: 9935053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.
    Lebtahi R; Le Cloirec J; Houzard C; Daou D; Sobhani I; Sassolas G; Mignon M; Bourguet P; Le Guludec D
    J Nucl Med; 2002 Jul; 43(7):889-95. PubMed ID: 12097458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.
    Asnacios A; Courbon F; Rochaix P; Bauvin E; Cances-Lauwers V; Susini C; Schulz S; Boneu A; Guimbaud R; Buscail L
    J Clin Oncol; 2008 Feb; 26(6):963-70. PubMed ID: 18281671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indium-111-pentetreotide uptake in endocrine tumors and lymphoma.
    Leners N; Jamar F; Fiasse R; Ferrant A; Pauwels S
    J Nucl Med; 1996 Jun; 37(6):916-22. PubMed ID: 8683311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide.
    Balon HR; Goldsmith SJ; Siegel BA; Silberstein EB; Krenning EP; Lang O; Donohoe KJ;
    J Nucl Med; 2001 Jul; 42(7):1134-8. PubMed ID: 11438641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.